Related Experiment Videos
[Changes in left ventricular filling in obstructive cardiomyopathies during long term beta blockade]
Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 1, 1980
Summary
Beta blockade significantly improves left ventricular filling in hypertrophic cardiomyopathy patients, leading to symptomatic relief. Non-responders show persistent filling abnormalities due to irreversible cardiac morphology changes.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertrophic cardiomyopathy (HCM) is a complex cardiac condition.
- Left ventricular (LV) filling abnormalities are common in HCM, impacting symptoms.
Purpose:
- To investigate the mechanism of symptomatic improvement in patients with obstructive hypertrophic cardiomyopathy during long-term oral beta-blockade therapy.
- To identify predictors of response to beta-blockade in HCM.
Summary:
- This study examined LV filling using echocardiography and cineangiography in 37 obstructive HCM patients before and during propranolol treatment.
- Clinical improvement correlated strongly with enhanced LV filling parameters, including maximum filling velocity and duration.
- Two patient groups emerged: 'reactors' with improved filling and asymptomatic status, and 'non-reactors' with poor filling due to irreversible morphological changes.
Impact:
- Beta-blockade therapy can significantly improve LV filling dynamics in HCM patients.
- Identifying 'reactors' and 'non-reactors' aids in understanding treatment response and prognosis in HCM.
- Findings highlight the role of LV filling and morphology in HCM management and therapeutic outcomes.